Home
Home

non-small cell lung cancer

Roche's Tarceva Progresses in Japan

Roche's Tarceva Progresses in Japan
Yahoo/Zacks

Clovis / CO-1686: Value, Derived From Data, Supports The Valuation

Clovis / CO-1686: Value, Derived From Data, Supports The Valuation
Seeking Alpha

Synta Pharmaceuticals: A Promising Biotech Stock for 2013

Synta Pharmaceuticals: A Promising Biotech Stock for 2013
Motley Fool

NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting

NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting
Yahoo/PR Newswire

Encouraging News for Peregrine Pharma

Encouraging News for Peregrine Pharma
Yahoo/Zacks

AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials

AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials
Bloomberg

Bristol-Myers Has The Future Of Oncology Therapies

Bristol-Myers Has The Future Of Oncology Therapies
Seeking Alpha

Array's Up-Coming Value Enhancing Catalysts

Array's Up-Coming Value Enhancing Catalysts
Seeking Alpha

ImmunoGen Offers New Hope For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Cancers

ImmunoGen Offers New Hope For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Cancers
Seeking Alpha

ARIAD presents new preclinical data on ponatinib

ARIAD presents new preclinical data on ponatinib
The Fly on the Wall